Please login to the form below
anaesthetics
This page shows the latest anaesthetics news and features for those working in and with pharma, biotech and healthcare.
Heron boosted by new data for ‘breakthrough’ pain drug
Heron Pharma has new data on its combination anaesthetic drug, and a breakthrough designation from the FDA, which suggests it could have an impact on the post-operative pain market. ... Heron’s rival candidate – called HTX-011 – pairs up a new
Latest news
-
Iontas gets UK backing for chronic pain antibody project
to the central nervous system and are blocked by some local anaesthetics such as lidocaine.
-
It’s all about patient outcomes… right?
In late 1846, a dentist from New England, William TG Morton, is attributed to have performed a dental extraction using diethyl ether as a general anaesthetic. ... Routledge; London, UK, 2002. Snow SJ. Blessed Days of Anaesthesia: How Anaesthetics Changed
-
Grünenthal buys Zomig rights as AZ slimming drive continues
This work has seen it agree deals with TerSera Therapeutics ($320m for Zoladex), ProStakan ($70m for Moventig), Aspen ($770m for seven anaesthetics drugs) and, most recently, Recordati ($300m for two blood
-
J&J therapy for suicidal depressives 'a breakthrough', says FDA
Esketamine is a derivative of ketamine - arguably better known as a party drug but which has been used at high doses as an anaesthetic for decades - and is around twice as
-
AstraZeneca sells rights to seven anaesthetics in $770m deal
topical anaesthetics Diprivan (propofol) and EMLA (lidocain and prilocaine), plus five local anaesthetics. ... through AGI, working alongside an acknowledge pioneer and leader in the field of anaesthetics”.
More from news
Approximately 1 fully matching, plus 23 partially matching documents found.
Latest Intelligence
-
Deal Watch October 2016
200+. Janssen / J&J (US). Piramal (IN). Asset acquisition. 5 injectable pain / anaesthetic products.
-
Deal Watch September 2016
500. GSK / Aspen. Asset acquisition. Sale of anaesthetic drugs [Ultiva, Nimbex, Tracrium, Mivacron and Anectinein – excludes US/CA rights].
-
Deal Watch June 2016
Meanwhile AstraZeneca has out-licensed ex-US rights to a portfolio of seven anaesthetics to Aspen. ... Paying $520m upfront Aspen gains access to a series of local anaesthetics including Marcaine (bupivacaine) and Xylocaine (lidocaine/ lignocaine), and
-
Pharma deals in June 2015
Neosaxitoxin, novel anaesthetic for local anaesthesia and post-op pain management. Collaboration, licence.
-
Pharma deals during March 2014
Baxter's medical products business has annual sales of over $9bn and a portfolio of intravenous solutions and nutritional therapies, drug delivery systems, premixed and other injectable drugs, inhalation anaesthetics and
More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.
Latest from PMHub
-
It’s all about patient outcomes… right?
In late 1846, a dentist from New England, William TG Morton, is attributed to have performed a dental extraction using diethyl ether as a general anaesthetic. ... Routledge; London, UK, 2002. Snow SJ. Blessed Days of Anaesthesia: How Anaesthetics Changed
-
"Legal highs" ruling leaves illegal labs laughing
These include the anaesthetic nitrous oxide, or laughing gas. N2O has been used as a recreational drug since 1799, when 'laughing gas parties' were popular among the ruling classes.
-
"Legal highs" ruling leaves illegal labs laughing
These include the anaesthetic nitrous oxide, or laughing gas. N2O has been used as a recreational drug since 1799, when 'laughing gas parties' were popular among the ruling classes.
-
Hayward Medical Communications
Allergic Disorders. Anaesthetics. Anti-infectives. Cancer/oncology. Cardiovascular. Central nervous system (CNS). Contraception.
-
Healthcare 2025: what the future holds for pharma
This was led by major advances in three core areas:. Health: Access to innovative medicines, surgery and anaesthetics, clean air and water.
More from PMHub
Approximately 0 fully matching, plus 5 partially matching documents found.
Featured jobs
- Home based, Editorial Team Leader, Medical Communications
-
Excellent package
- Head of Market Access - International - Based Cambridge
-
Excellent Basic, Bonus and Flex Benefits
-
Account Manager
-
£40, 000 - £45, 000 benefits
- Home based, Chief Medical Writer, Medical Communications
-
Excellent package
- Account Director, Consumer Healthcare PR, Global PR agency
-
£50, 000 – £58, 000
- Home based, Senior Medical Writer, Medical Communications
-
Excellent package
- Senior Medical Writer, Healthcare Advertising Agency
-
£45, 000 – £50, 000
- Business Unit Head, Medical Communications, London
-
Excellent package
- Account Director, Medical Communications
-
C£50 – 65, 000 benefits and bonus
- Account Manager, Medical Communications and Marketing
-
£30, 000 – £40, 000 benefits and bonus
- Home based, Principal Medical Writer, Medical Communications
-
Excellent package
- Strategic Planner, Healthcare Advertising
-
£47, 000 – £53, 000
- Principal Medical Writer / Editorial Director – Medical Communic...
-
£60, 000 - £80, 000
-
Client Services Director - Med Comms
-
Great salary and bebefits
-
Healthcare PR Director
-
£100, 000 – £120, 000 benefits
Subscribe to our email news alerts
- Brexit rebels win vote on European Medicines Agency alignment
- AstraZeneca joins Merck in Brexit stockpiling effort
- NHS England to Vertex: come clean on Orkambi offer
- Moving annual total (MAT)
- Vyriad inks immunotherapy alliance with Merck/Pfizer
- J&J’s Invokana aces diabetic kidney disease trial, setting up filings
- Random42 win Creativity International Award for Scientific Animation
- Merck & Co joins big pharma pricing pledge – but sceptics unconvinced
- Aurora partners with PIPHealth and taps into patient panels
- FDA’s Gottlieb lambasts industry’s biosimilar-blocking tactics
- Allergan’s abicipar matches AMD blockbuster Lucentis in phase III
- OUTiCO growth in multi-channel creates more job openings
PMHub
Makara Health
Independent healthcare communications agency with a passion to develop inspirational ideas that create sustained and positive change. Whether it is...
Latest intelligence
- Developing advocacy in the pharmaceutical industry.
- The importance of advocacy programmes...
- GDPR and events. What does the pharma industry need to know?
- Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
- Digital trends in B2B sales - how far behind is Pharma?
- The modern approach to B2B sales is data-driven, and enabled by digital tools....
Quick links
Infographics
